These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 17033962)

  • 1. Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies.
    Zhou H; Brockington M; Jungbluth H; Monk D; Stanier P; Sewry CA; Moore GE; Muntoni F
    Am J Hum Genet; 2006 Nov; 79(5):859-68. PubMed ID: 17033962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of recessive RYR1 mutations in core myopathies.
    Zhou H; Yamaguchi N; Xu L; Wang Y; Sewry C; Jungbluth H; Zorzato F; Bertini E; Muntoni F; Meissner G; Treves S
    Hum Mol Genet; 2006 Sep; 15(18):2791-803. PubMed ID: 16940308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies.
    Zhou H; Jungbluth H; Sewry CA; Feng L; Bertini E; Bushby K; Straub V; Roper H; Rose MR; Brockington M; Kinali M; Manzur A; Robb S; Appleton R; Messina S; D'Amico A; Quinlivan R; Swash M; Müller CR; Brown S; Treves S; Muntoni F
    Brain; 2007 Aug; 130(Pt 8):2024-36. PubMed ID: 17483490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
    Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound RYR1 heterozygosity resulting in a complex phenotype of malignant hyperthermia susceptibility and a core myopathy.
    Kraeva N; Heytens L; Jungbluth H; Treves S; Voermans N; Kamsteeg E; Ceuterick-de Groote C; Baets J; Riazi S
    Neuromuscul Disord; 2015 Jul; 25(7):567-76. PubMed ID: 25958340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Landrieu P; Nivoche Y; Fardeau M; Lunardi J
    Hum Mol Genet; 2001 Oct; 10(22):2581-92. PubMed ID: 11709545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores.
    Monnier N; Marty I; Faure J; Castiglioni C; Desnuelle C; Sacconi S; Estournet B; Ferreiro A; Romero N; Laquerriere A; Lazaro L; Martin JJ; Morava E; Rossi A; Van der Kooi A; de Visser M; Verschuuren C; Lunardi J
    Hum Mutat; 2008 May; 29(5):670-8. PubMed ID: 18253926
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zullo A; Perrotta G; D'Angelo R; Ruggiero L; Gravino E; Del Vecchio L; Santoro L; Salvatore F; Carsana A
    Biomed Res Int; 2019; 2019():7638946. PubMed ID: 31165076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
    Jungbluth H; Lillis S; Zhou H; Abbs S; Sewry C; Swash M; Muntoni F
    Neuromuscul Disord; 2009 May; 19(5):344-7. PubMed ID: 19303294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo RyR1 reduction in muscle triggers a core-like myopathy.
    Pelletier L; Petiot A; Brocard J; Giannesini B; Giovannini D; Sanchez C; Travard L; Chivet M; Beaufils M; Kutchukian C; Bendahan D; Metzger D; Franzini Armstrong C; Romero NB; Rendu J; Jacquemond V; Fauré J; Marty I
    Acta Neuropathol Commun; 2020 Nov; 8(1):192. PubMed ID: 33176865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central core disease due to recessive mutations in RYR1 gene: is it more common than described?
    Kossugue PM; Paim JF; Navarro MM; Silva HC; Pavanello RC; Gurgel-Giannetti J; Zatz M; Vainzof M
    Muscle Nerve; 2007 May; 35(5):670-4. PubMed ID: 17226826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.
    Tilgen N; Zorzato F; Halliger-Keller B; Muntoni F; Sewry C; Palmucci LM; Schneider C; Hauser E; Lehmann-Horn F; Müller CR; Treves S
    Hum Mol Genet; 2001 Dec; 10(25):2879-87. PubMed ID: 11741831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of muscle strength in a mouse model for congenital myopathy treated with HDAC and DNA methyltransferase inhibitors.
    Ruiz A; Benucci S; Duthaler U; Bachmann C; Franchini M; Noreen F; Pietrangelo L; Protasi F; Treves S; Zorzato F
    Elife; 2022 Mar; 11():. PubMed ID: 35238775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced threshold for store overload-induced Ca
    Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
    Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.
    Samões R; Oliveira J; Taipa R; Coelho T; Cardoso M; Gonçalves A; Santos R; Melo Pires M; Santos M
    J Neuromuscul Dis; 2017; 4(1):67-76. PubMed ID: 28269792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene.
    Jungbluth H; Zhou H; Hartley L; Halliger-Keller B; Messina S; Longman C; Brockington M; Robb SA; Straub V; Voit T; Swash M; Ferreiro A; Bydder G; Sewry CA; Müller C; Muntoni F
    Neurology; 2005 Dec; 65(12):1930-5. PubMed ID: 16380615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bi-allelic expression of the RyR1 p.A4329D mutation decreases muscle strength in slow-twitch muscles in mice.
    Elbaz M; Ruiz A; Nicolay S; Tupini C; Bachmann C; Eckhardt J; Benucci S; Pelczar P; Treves S; Zorzato F
    J Biol Chem; 2020 Jul; 295(30):10331-10339. PubMed ID: 32499372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative RyR1 reduction and loss of calcium sensitivity of RyR1Q1970fsX16+A4329D cause cores and loss of muscle strength.
    Elbaz M; Ruiz A; Bachmann C; Eckhardt J; Pelczar P; Venturi E; Lindsay C; Wilson AD; Alhussni A; Humberstone T; Pietrangelo L; Boncompagni S; Sitsapesan R; Treves S; Zorzato F
    Hum Mol Genet; 2019 Sep; 28(18):2987-2999. PubMed ID: 31044239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic allele silencing and variable penetrance of malignant hyperthermia susceptibility.
    Robinson RL; Carpenter D; Halsall PJ; Iles DE; Booms P; Steele D; Hopkins PM; Shaw MA
    Br J Anaesth; 2009 Aug; 103(2):220-5. PubMed ID: 19454545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.